SGX Group has sold its subsidiary Scientific Beta for 23 million euros, as part of its active portfolio management and sharper focus on growth priorities.
Scientific Beta, based in Nice, France, is described as a specialised research-based index provider, focusing on multi-factor, single factor, and diversified equity strategies.
STOXX, part of the ISS STOXX group of companies and leading provider of benchmark and custom index solutions for global institutional investors, is the new owner.
"We are pleased to transition Scientific Beta to a new owner well-positioned to scale its capabilities and distribution," says Ng Yao Loong, SGX's head of global financial markets.
"This divestment allows SGX to focus on areas where we see the strongest opportunities to deliver impact for our clients, partners and shareholders, and to further strengthen our multi-asset offering," he adds.
Following the transaction, SGX will retain its global multi-asset iEdge platform and continue to build on its index business as part of its broader multi-asset offering.
See also: Hock Lian Seng issues profit warning; expects to report operating loss for 1HFY2026
SGX took a 93% stake in Scientific Beta for 186 million euros back in Jan 2020.
For SGX's 1HFY2026 ended Dec 2025, net loss attributable to Scientific Beta, including goodwill impairment loss, was around $15 million.
As at Dec 2025, NAV of Scientific Beta, including goodwill and cash, was around $75 million and NTA was around $17 million.
See also: Trendlines portfolio company NICE Surgical granted US patent for purse-string stapler
In its separate announcement of this deal, STOXX says with Scientific Beta, it will strengthen its position as a leading provider of systematic, research-driven index solutions.
Originally founded within EDHEC-Risk Institute, Scientific Beta is known for translating academic research into transparent, rules-based equity strategies designed for institutional investors.
The firm, founded in 2012, has around 40 full-time employees based primarily in Nice as well as London, Singapore, and Sydney.
The acquisition combines Scientific Beta’s academically grounded factor research and signal design capabilities with STOXX’s index expertise to deliver factor indices.
“This acquisition will accelerate our strategy to deliver scalable, research-driven, and cost-effective index solutions to institutional investors globally,” says Gary Retelny, president and CEO of ISS STOXX.
"It strengthens our ability to meet the growing demand for systematic, rules-based strategies that are undergirded by world-class research, for institutional investors across the globe," he adds.
SGX shares closed at $24.01, down 0.66%
